Insider Transactions Reported by 21 Insiders of Orchestra BioMed Holdings, Inc.

Symbol
OBIO on Nasdaq
Location
150 Union Square Drive, New Hope, PA

Insiders trading volume in the past year

Orchestra BioMed Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Medtronic plc 10%+ Owner $94.1M Dec 31, 2023
Roderick Wong Chief Executive Officer, Director, 10%+ Owner $45M Jan 24, 2023
Rtw Investments, Lp 10%+ Owner $34.8M +$10.3M +41.8% Aug 4, 2025
Perceptive Advisors Llc 10%+ Owner $18.7M +$6.05M +47.9% Aug 1, 2025
HSAC 2 Holdings, LLC 10%+ Owner $8.78M Aug 5, 2024
Darren Sherman President and Chief Operating Officer, Director $4.53M +$7.86K +0.17% Nov 25, 2025
David P. Hochman Chief Executive Officer and Chairperson, Director $3.61M +$133K +3.83% Nov 14, 2025
Andrew Taylor Chief Financial Officer $2.48M +$9.93K +0.4% Nov 25, 2025
William Reed Little Executive Vice President, Corporate Development & Strategy $2.16M May 30, 2024
Jason Aryeh Director $266K +$2.45K +0.93% Sep 19, 2025
Eric S. Fain Director $187K +$6.85K +3.8% Aug 25, 2025
Michael Kaswan Chief Financial Officer $176K Apr 12, 2023
Pamela Ann Connealy Director $131K Aug 7, 2025
David Pacitti Director $121K Aug 7, 2025
John Prosper Mack Director $108K Aug 7, 2025
Chris Cleary Director $101K Aug 7, 2025
Yuval Mika General Manager and Chief Technology Officer, Bioelectronic Therapies $96.7K May 8, 2024
Eric A. Md Rose Director $52.8K Jun 20, 2024
Joshua Aiello Principal Accounting Officer $47K Sep 17, 2025
Geoffrey Wade Smith Director $22.6K Jul 20, 2023
George Papandreou General Manager and Senior Vice President, Focal Therapies $21.6K May 8, 2024

Recent Insider Transactions by Companies or Individuals for Orchestra BioMed Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.